Is Etanercept 25mg once weekly as effective as 50mg at maintaining response in patients with ankylosing spondylitis? A randomized control trial

Max Yates; Louise E. Hamilton; Frances Elender; Loretta Dean; Helen Doll; Alex J. MacGregor; Joegi Thomas; Karl Gaffney

doi:10.3899/jrheum.141335

Is Etanercept 25mg once weekly as effective as 50mg at maintaining response in patients with ankylosing spondylitis? A randomized control trial

Max Yates, Louise E. Hamilton, Frances Elender, Loretta Dean, Helen Doll, Alex J. MacGregor, Joegi Thomas, Karl Gaffney (Lead Author)

Research output: Contribution to journal › Article › peer-review

47 Citations (Scopus)

8 Downloads (Pure)

Abstract

To investigate, in a pilot randomized controlled trial, whether etanercept (ETN) 25 mg once weekly is effective at maintaining a clinical response in patients with ankylosing spondylitis (AS) who have responded to the standard 50 mg dose.

Original language	English
Pages (from-to)	1177-1185
Number of pages	9
Journal	Journal of Rheumatology
Volume	42
Issue number	7
Early online date	1 Jun 2015
DOIs	https://doi.org/10.3899/jrheum.141335
Publication status	Published - Jul 2015

Keywords

Ankylosing Spondylitis
Anti-tumor necrosis factor therapy
etanercept
randomized control trial

Access to Document

10.3899/jrheum.141335

FinalAnswersClean 10th Mar2015Accepted author manuscript, 71.7 KB

Cite this

@article{83d9e3958ea141d18af61003918e4e8e,

title = "Is Etanercept 25mg once weekly as effective as 50mg at maintaining response in patients with ankylosing spondylitis? A randomized control trial",

abstract = "To investigate, in a pilot randomized controlled trial, whether etanercept (ETN) 25 mg once weekly is effective at maintaining a clinical response in patients with ankylosing spondylitis (AS) who have responded to the standard 50 mg dose.",

keywords = "Ankylosing Spondylitis, Anti-tumor necrosis factor therapy, etanercept, randomized control trial",

author = "Max Yates and Hamilton, {Louise E.} and Frances Elender and Loretta Dean and Helen Doll and MacGregor, {Alex J.} and Joegi Thomas and Karl Gaffney",

year = "2015",

month = jul,

doi = "10.3899/jrheum.141335",

language = "English",

volume = "42",

pages = "1177--1185",

journal = "Journal of Rheumatology",

issn = "0315-162X",

publisher = "Journal of Rheumatology",

number = "7",

}

TY - JOUR

T1 - Is Etanercept 25mg once weekly as effective as 50mg at maintaining response in patients with ankylosing spondylitis? A randomized control trial

AU - Yates, Max

AU - Hamilton, Louise E.

AU - Elender, Frances

AU - Dean, Loretta

AU - Doll, Helen

AU - MacGregor, Alex J.

AU - Thomas, Joegi

AU - Gaffney, Karl

PY - 2015/7

Y1 - 2015/7

N2 - To investigate, in a pilot randomized controlled trial, whether etanercept (ETN) 25 mg once weekly is effective at maintaining a clinical response in patients with ankylosing spondylitis (AS) who have responded to the standard 50 mg dose.

AB - To investigate, in a pilot randomized controlled trial, whether etanercept (ETN) 25 mg once weekly is effective at maintaining a clinical response in patients with ankylosing spondylitis (AS) who have responded to the standard 50 mg dose.

KW - Ankylosing Spondylitis

KW - Anti-tumor necrosis factor therapy

KW - etanercept

KW - randomized control trial

U2 - 10.3899/jrheum.141335

DO - 10.3899/jrheum.141335

M3 - Article

C2 - 26034151

VL - 42

SP - 1177

EP - 1185

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 7

ER -